BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 33143250)

  • 1. Spliceosome-Associated microRNAs Signify Breast Cancer Cells and Portray Potential Novel Nuclear Targets.
    Mahlab-Aviv S; Zohar K; Cohen Y; Peretz AR; Eliyahu T; Linial M; Sperling R
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.
    Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM
    BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
    Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
    J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA LINC00662 promotes proliferation and migration of breast cancer cells via regulating the miR-497-5p/EglN2 axis.
    Cheng L; Xing Z; Zhang P; Xu W
    Acta Biochim Pol; 2020 Jun; 67(2):229-237. PubMed ID: 32558530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
    Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
    Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics prediction and experimental validation of a novel microRNA: hsa-miR-B43 within human CDH4 gene with a potential metastasis-related function in breast cancer.
    Rahimi A; Sedighi R; Emadi-Baygi M; Honardoost MA; Mowla SJ; Khanahmad H; Nikpour P
    J Cell Biochem; 2020 Feb; 121(2):1307-1316. PubMed ID: 31489987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide miRNA response to anacardic acid in breast cancer cells.
    Schultz DJ; Muluhngwi P; Alizadeh-Rad N; Green MA; Rouchka EC; Waigel SJ; Klinge CM
    PLoS One; 2017; 12(9):e0184471. PubMed ID: 28886127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caprin-1 is a novel microRNA-223 target for regulating the proliferation and invasion of human breast cancer cells.
    Gong B; Hu H; Chen J; Cao S; Yu J; Xue J; Chen F; Cai Y; He H; Zhang L
    Biomed Pharmacother; 2013 Sep; 67(7):629-36. PubMed ID: 23953883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA HAGLR acts as a microRNA-143-5p sponge to regulate epithelial-mesenchymal transition and metastatic potential in esophageal cancer by regulating LAMP3.
    Yang C; Shen S; Zheng X; Ye K; Sun Y; Lu Y; Ge H
    FASEB J; 2019 Sep; 33(9):10490-10504. PubMed ID: 31311326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential altered expression of let-7a and miR-205 tumor-suppressor miRNAs in different subtypes of breast cancer under treatment with Taxol.
    Asghari F; Haghnavaz N; Shanehbandi D; Khaze V; Baradaran B; Kazemi T
    Adv Clin Exp Med; 2018 Jul; 27(7):941-945. PubMed ID: 30019863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells.
    Rasheed SA; Teo CR; Beillard EJ; Voorhoeve PM; Zhou W; Ghosh S; Casey PJ
    Mol Cancer; 2015 Mar; 14():67. PubMed ID: 25889182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signature microRNAs of nuclear Sm complex associated with breast cancer tumorigenesis.
    Zhang X; Shen B; Cui Y
    J Cell Biochem; 2018 Jul; 119(7):5426-5436. PubMed ID: 29363793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
    Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
    Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of exosomal miR-9 and miR-155 targeting PTEN and DUSP14 in highly metastatic breast cancer and their effect on low metastatic cells.
    Kia V; Paryan M; Mortazavi Y; Biglari A; Mohammadi-Yeganeh S
    J Cell Biochem; 2019 Apr; 120(4):5666-5676. PubMed ID: 30335891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
    Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor suppressor microRNAs are downregulated in myelodysplastic syndrome with spliceosome mutations.
    Aslan D; Garde C; Nygaard MK; Helbo AS; Dimopoulos K; Hansen JW; Severinsen MT; Treppendahl MB; Sjø LD; Grønbæk K; Kristensen LS
    Oncotarget; 2016 Mar; 7(9):9951-63. PubMed ID: 26848861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The RNA-binding protein SART3 promotes miR-34a biogenesis and G
    Sherman EJ; Mitchell DC; Garner AL
    J Biol Chem; 2019 Nov; 294(46):17188-17196. PubMed ID: 31619517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Robust expression of tumor suppressor miRNA's let-7 and miR-195 detected in plasma of Saudi female breast cancer patients.
    Qattan A; Intabli H; Alkhayal W; Eltabache C; Tweigieri T; Amer SB
    BMC Cancer; 2017 Nov; 17(1):799. PubMed ID: 29183284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The highly expressed 5'isomiR of hsa-miR-140-3p contributes to the tumor-suppressive effects of miR-140 by reducing breast cancer proliferation and migration.
    Salem O; Erdem N; Jung J; Münstermann E; Wörner A; Wilhelm H; Wiemann S; Körner C
    BMC Genomics; 2016 Aug; 17():566. PubMed ID: 27502506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
    Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
    Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.